Analyst Profile

Followed by 39 followers
.
Salim Syed

Salim Syed

Mizuho Securities
Wall Street Analyst
#8,023 out of 8,141 Wall Street Analysts
#23,798 out of 24,284 experts

Success Rate

34%
92 out of 274 transactions made a profit

Average Return

-17.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Salim Syed's trades since 2018 and holding each position for 1 Year would result in 33.58% of your transactions generating a profit, with an average return of -17.7% per rating.

Stock Rating Distribution

762Ratings
82.41% Buy
17.59% Hold
0.00% Sell
Distribution of Salim Syed's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Wave Life Sciences Pte. Ltd
(WVE)
Rating:Buy
Date:May 12, 2022 - Today
Return:+226.30%
The most profitable rating made by Salim Syed

Salim Syed's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Endo International
Jul 13, 2018
Hold
Reiterated
1Ratings
0.00%
Orion Group Holdings
Jul 02, 2019
Buy
Reiterated
$7.10
(172.03% Upside)
1Ratings
100%
+7.50%
CELG
Celgene
Nov 22, 2019
Hold
Assigned
34Ratings
83%
+6.13%
NTGN
Neon Therapeutics
May 08, 2020
Hold
Assigned
11Ratings
50%
+15.53%
PPPMF
Primero Mining Corp
Nov 23, 2020
Hold
Reiterated
10Ratings
0.00%
Provident Financial Services
Aug 04, 2022
Buy
Reiterated
$25.00
(13.53% Upside)
1Ratings
0%
-4.40%
BioMarin Pharmaceutical
Nov 03, 2022
Buy
Reiterated
$23.00
(-76.69% Downside)
1Ratings
100%
+15.20%
Amgen
Nov 07, 2022
Hold
Reiterated
$208.00
(-26.40% Downside)
139Ratings
80%
+9.68%
BridgeBio Pharma
Nov 07, 2022
Buy
Reiterated
$23.00
(183.95% Upside)
55Ratings
26%
-22.46%
Gilead Sciences
Nov 08, 2022
Buy
Reiterated
$88.00
(3.27% Upside)
81Ratings
68%
+11.79%
List of latest recommendations made by Salim Syed. Click to expand and see Salim Syed's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >